{{Rsnum
|rsid=3737548
|Gene=COL2A1
|Chromosome=12
|position=47997633
|Orientation=minus
|GMAF=0.2167
|Assembly=GRCh38
|GenomeBuild=38.1
|dbSNPBuild=141
|geno1=(A;A)
|geno2=(A;C)
|geno3=(C;C)
|Gene_s=COL2A1
}}{{ population diversity
| geno1=(A;A)
| geno2=(A;C)
| geno3=(C;C)
| CEU | 0.0 | 0.0 | 0.0
| HCB | 11.1 | 53.3 | 35.6
| JPT | 11.4 | 40.9 | 47.7
| YRI | 0.0 | 0.0 | 0.0
| ASW | 0.0 | 0.0 | 0.0
| CHB | 11.1 | 53.3 | 35.6
| CHD | 0.0 | 0.0 | 0.0
| GIH | 0.0 | 0.0 | 0.0
| LWK | 0.0 | 0.0 | 0.0
| MEX | 0.0 | 0.0 | 0.0
| MKK | 0.0 | 0.0 | 0.0
| TSI | 0.0 | 0.0 | 0.0
| HapMapRevision=28
}}{{PMID Auto
|PMID=19019890
|Title=COL2A1 gene polymorphisms and susceptibility to osteoarthritis of the hand in Finnish women
}}{{PMID|18523590|OA=1
}} Genetic and epigenetic factors at COL2A1 and ABCA4 influence clinical outcome in congenital toxoplasmosis.

{{PMID|19430638|OA=1
}} Host genetic and epigenetic factors in toxoplasmosis.